ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,575Medicare Part D Prescriptions Filled, Including Refills

Rank: 356 out of 1383

$628K Total Retail Price of All Prescriptions

Rank: 221 out of 1383

773 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
68% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 773 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 6,934 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
AMLODIPINE BESYLATE 488 390 1 6
PRAVASTATIN SODIUM 413 334 2 14
SIMVASTATIN 374 312 3 2
LISINOPRIL 297 214 4 3
FUROSEMIDE 240 182 5 7
CARVEDILOL 236 159 6 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 223 173 7 27
GLIMEPIRIDE 174 111 8 31
OMEPRAZOLE 173 97 9 5
HYDROCHLOROTHIAZIDE 170 149 10 10
AMLODIPINE BESYLATE-BENAZEPRIL 170 133 10 68
METFORMIN HCL ER 162 104 12 47
DIOVAN HCT 157 146 13 103
METOPROLOL TARTRATE 142 109 14 9
MELOXICAM 140 114 15 20
PEN NEEDLE 126 81 16 147
CLOPIDOGREL 123 81 17 28
RANITIDINE HCL 123 82 17 19
METFORMIN HCL 119 71 19 8
LEVOTHYROXINE SODIUM 117 97 20 4
TRIAMTERENE-HCTZ 116 91 21 48
PLAVIX 115 90 22 43
BENAZEPRIL HCL 115 90 22 38
POTASSIUM CHLORIDE 99 84 24 12
TERBINAFINE HCL 97 61 25 336
WARFARIN SODIUM 95 62 26 13
LANTUS SOLOSTAR 87 49 27 112
TAMSULOSIN HCL 83 68 28 30
SPIRONOLACTONE 79 63 29 67
KLOR-CON 10 75 51 30 74
ZOLPIDEM TARTRATE 74 60 31 17
HUMALOG MIX 75-25 71 39 32 299
METOPROLOL SUCCINATE 69 55 33 29
ATORVASTATIN CALCIUM 65 46 34 18
LYRICA 64 48 35 72
VERAPAMIL ER 63 63 36 84
NEXIUM 62 55 37 26
LACTULOSE 62 13 37 128
NAPROXEN 62 45 37 105
TRAMADOL HCL 61 35 40 25
ATENOLOL 60 40 41 16
AMITRIPTYLINE HCL 60 51 R 41 57
HYDRALAZINE HCL 59 45 43 86
ETODOLAC 57 46 44 198
HYDROCODONE-ACETAMINOPHEN 53 42 S3 45 1
TRIAMTERENE-HYDROCHLOROTHIAZID 51 36 46 154
LOSARTAN POTASSIUM 50 40 47 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 27, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.